Abstract
The crystal and molecular structure of the pure (S)-enantiomer of the popular analgesic and anti-inflammatory drug ketoprophen (α-ket) is reported. A detailed aspherical charge-density model based on high-resolution X-ray diffraction data has been refined, yielding a high-precision geometric description and classification of the O-H...O interactions as medium strength hydrogen bonds. The crystal structure of the racemic form of ketoprophen (β-ket) was also redetermined at 100 K, at 0.5 Å resolution. A previously unreported disorder (10% occupancy) was discovered. In contrast to the racemic β-ket case, the (S)-enantiomer crystallizes with two independent molecules in the asymmetric unit with two distinct conformations. The major difference between the β-ket and α-ket crystal forms lies in the formation of distinct hydrogen-bonded motifs: A closed ring motif in β-ket versus infinite chains of hydrogen bonds in the chiral α-ket structure. However, the overall crystal packing of both forms is surprisingly similar, with close-packed layers of antiparallel-oriented benzo-phenone moieties bound by C-H...π interactions. Notably, the most important stabilizing term in the total lattice energies in both instances proved to be the dispersion related to these interactions. Both forms of the title compound (α- A nd β-ket) were additionally characterized by differential scanning calorimetry and thermogravimetric analysis.
Original language | English |
---|---|
Pages (from-to) | 841-853 |
Number of pages | 13 |
Journal | IUCrJ |
Volume | 5 |
DOIs | |
State | Published - 2018 |
Externally published | Yes |
Funding
This work was financially supported within the Polish NCN MAESTRO grant: DEC-2012/04/A/ST5/00609. Theoretical calculations were performed at the Wrocław Centre for Networking and Supercomputing and using the PL-Grid infrastructure. The authors would like to thank Dr Anna Hoser for fruitful scientific discussions. Single-crystal X-ray diffraction analysis was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007–2013. The data were collected at the Core Facility for crystallographic and biophysical research, sponsored by the Foundation for Polish Science (FNP).
Funders | Funder number |
---|---|
FNP | |
Polish NCN | DEC-2012/04/A/ST5/00609 |
European Geosciences Union | |
Fundacja na rzecz Nauki Polskiej | |
Uniwersytet Warszawski | |
European Regional Development Fund | |
Guts UK |
Keywords
- bioinversion
- charge density
- crystal structures
- ketoprophen
- pharmaceuticals